These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4028022)

  • 1. Ability of specific monoclonal antibodies and conventional antisera conjugated to hematoporphyrin to label and kill selected cell lines subsequent to light activation.
    Mew D; Lum V; Wat CK; Towers GH; Sun CH; Walter RJ; Wright W; Berns MW; Levy JG
    Cancer Res; 1985 Sep; 45(9):4380-6. PubMed ID: 4028022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A monoclonal antibody to myelogenous leukemia: isolation and characterization.
    Malcolm AJ; Shipman RC; Logan PM; Levy JG
    Exp Hematol; 1984 Aug; 12(7):539-47. PubMed ID: 6589167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of a common leukemia-associated antigen in human myelogenous leukemia using immunoperoxidase.
    Logan PM; Malcolm AJ; Levy JG
    Diagn Immunol; 1984; 2(2):86-100. PubMed ID: 6238754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strong, specific anti-human leukemia antisera prepared with the use of purified cell membrane antigen.
    Negoro S; Seon BK
    Cancer Res; 1981 Jul; 41(7):2973-6. PubMed ID: 6972802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L; Fuji H
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
    Raso V; Ritz J; Basala M; Schlossman SF
    Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific killing of human T-leukemia cells by immunotoxins prepared with ricin A chain and monoclonal anti-human T-cell leukemia antibodies.
    Seon BK
    Cancer Res; 1984 Jan; 44(1):259-64. PubMed ID: 6606488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a monoclonal antibody (5E9) that defines a human cell surface antigen of cell activation.
    Haynes BF; Hemler M; Cotner T; Mann DL; Eisenbarth GS; Strominger JL; Fauci AS
    J Immunol; 1981 Jul; 127(1):347-51. PubMed ID: 6787129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
    Tong AW; Lee J; Stone MJ
    Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides.
    Haynes BF; Bunn P; Mann D; Thomas C; Eisenbarth GS; Minna J; Fauci AS
    J Clin Invest; 1981 Feb; 67(2):523-30. PubMed ID: 6970206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a monoclonal antibody, KR-P8, that detects a new prostate-specific marker.
    Raynor RH; Hazra TA; Moncure CW; Mohanakumar T
    J Natl Cancer Inst; 1984 Sep; 73(3):617-25. PubMed ID: 6206270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-based nanotechnology: antibody conjugated with photosensitizer in targeted anticancer photoimmunotherapy.
    Jankun J
    Int J Oncol; 2011 Oct; 39(4):949-53. PubMed ID: 21725592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody against a unique antigen on human acute promyelocytic leukemia cell line (HL-60).
    Aota F; Chang D; Hill NO; Khan A
    Exp Hematol; 1982 Nov; 10(10):835-43. PubMed ID: 6759147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary studies on a more effective phototoxic agent than hematoporphyrin.
    Richter AM; Kelly B; Chow J; Liu DJ; Towers GH; Dolphin D; Levy JG
    J Natl Cancer Inst; 1987 Dec; 79(6):1327-32. PubMed ID: 3480384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
    Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
    Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.
    Ball ED; Graziano RF; Fanger MW
    J Immunol; 1983 Jun; 130(6):2937-41. PubMed ID: 6574189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody SN2 defining a human T cell leukemia-associated cell surface glycoprotein.
    Seon BK; Negoro S; Barcos MP; Tebbi CK; Chervinsky D; Fukukawa T
    J Immunol; 1984 Apr; 132(4):2089-95. PubMed ID: 6607954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of a unique tumor-associated surface antigen on L1210 leukemia cells recognized by semisyngeneic antisera.
    Yokochi T; Kawashima K; Nakashima I; Nagase F; Isobe K; Nagura E; Yamada K; Miyadai T; Kimura Y
    Cancer Res; 1987 Feb; 47(4):1006-9. PubMed ID: 3542198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of chemotherapeutic effects on L1210 cells using hematoporphyrin and light.
    Creekmore SP; Zaharko DS
    Cancer Res; 1983 Nov; 43(11):5252-7. PubMed ID: 6616462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.